Pyridine analogs as C5a antagonists
US7429666B2 · kind B2 · utility
5Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2005 |
| Grant date | Sep 30, 2008 |
| Priority date | — |
| Expiry date | Oct 1, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D215/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds of Formula I which are antagonists of the C5a receptor. Compounds of the present invention are useful for the treatment of various C5a-mediated diseases and disorders; accordingly the present invention provides a method for the treatment of C5a-mediated diseases using the novel compounds described herein, as well as pharmaceutical compositions containing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.